Solasia Pharma KK (4597)

Currency in JPY
37.0
0.0(0.00%)
Closed·
4597 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4597 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.038.0
52 wk Range
27.059.0
Key Statistics
Bid/Ask
37.00 / 38.00
Prev. Close
37
Open
38
Day's Range
37-38
52 wk Range
27-59
Volume
14.31M
Average Volume (3m)
15.9M
1-Year Change
-27.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4597 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Solasia Pharma KK Company Profile

Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers Episil, an oral liquid for oral mucositis/stomatitis; and DARVIAS, an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma. It also develops Sancuso for chemotherapy induced nausea and vomiting; SP-04, which is in preclinical trial development to treat chemotherapy peripheral neuropathy; and SP-05 for the treatment of colorectal cancer. The company was founded in 2006 and is based in Tokyo, Japan.

Employees
23
Market
Japan

Compare 4597 to Peers and Sector

Metrics to compare
4597
Peers
Sector
Relationship
P/E Ratio
−5.0x−6.8x−0.5x
PEG Ratio
0.270.010.00
Price/Book
7.4x4.1x2.6x
Price / LTM Sales
32.3x46.2x3.3x
Upside (Analyst Target)
224.3%68.1%38.9%
Fair Value Upside
Unlock9.7%5.4%Unlock

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-1.20 / --
Revenue / Forecast
24.00M / --
EPS Revisions
Last 90 days

4597 Income Statement

People Also Watch

228.2
9434
-1.93%
222.00
5255
-2.20%
895.00
290A
+4.19%

FAQ

What Stock Exchange Does Solasia Pharma Trade On?

Solasia Pharma is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Solasia Pharma?

The stock symbol for Solasia Pharma is "4597."

What Is the Solasia Pharma Market Cap?

As of today, Solasia Pharma market cap is 9.46B.

What Is Solasia Pharma's Earnings Per Share (TTM)?

The Solasia Pharma EPS (TTM) is -8.69.

When Is the Next Solasia Pharma Earnings Date?

Solasia Pharma will release its next earnings report on 16 Nov 2025.

From a Technical Analysis Perspective, Is 4597 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Solasia Pharma Stock Split?

Solasia Pharma has split 0 times.

How Many Employees Does Solasia Pharma Have?

Solasia Pharma has 23 employees.

What is the current trading status of Solasia Pharma (4597)?

As of 30 Aug 2025, Solasia Pharma (4597) is trading at a price of 37.0, with a previous close of 37.00. The stock has fluctuated within a day range of 37.0 to 38.0, while its 52-week range spans from 27.0 to 59.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.